Appointment
Sally Ann Forsyth to join SBC
Forsyth will be leaving her position as CEO of Norwich Research Park, which she joined in 2013, for SBC.
Stevenage Bioscience Catalyst opened as the UK's first open innovation biomedical campus in 2012 and is a joint venture between Government, GlaxoSmithKline and Wellcome.